1,2-dioctanoylglycerol has been researched along with Myocardial Infarction in 3 studies
1,2-dioctanoylglycerol: functions as bioregulator of protein kinase C in human platelets
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Speechly-Dick, ME | 1 |
| Mocanu, MM | 2 |
| Yellon, DM | 3 |
| Baxter, GF | 1 |
| Schulman, D | 1 |
| Latchman, DS | 1 |
3 other studies available for 1,2-dioctanoylglycerol and Myocardial Infarction
| Article | Year |
|---|---|
Protein kinase C. Its role in ischemic preconditioning in the rat.
Topics: Alkaloids; Analysis of Variance; Animals; Arrhythmias, Cardiac; Benzophenanthridines; Blood Pressure | 1994 |
Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivo.
Topics: Animals; Blood Pressure; Diglycerides; Enzyme Activation; Heart Rate; Heat-Shock Proteins; Hemodynam | 1997 |
Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.
Topics: Adenosine; Aging; Animals; Diazoxide; Diglycerides; Heart; Ischemic Preconditioning, Myocardial; Mal | 2001 |